Survival of first line biological and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in Chile Marcos Cruces Olivar, Allan D. Burboa, Yolanda M. Gómez

Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis Jesús Tornero-Molina, Mercedes Alperi-López, Ivan Castellví, Juan José de Agustín-de Oro, Alejandro Escudero, Rosario García-Vicuña, Miguel Ángel González-Gay, Cristina Hidalgo, Esteban Rubio, Raimon Sanmartí, Núria Casamira, Jaime Calvo-Alén

Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study Roxana González Mazarío, Jorge Juan Fragío Gil, José Ivorra Cortés, Elena Grau García, Antonio José Cañada Martínez, Luis González Puig, Rosa María Negueroles Albuixech, José Andrés Román Ivorra